Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
CRITICAL RISK
Score updated Oct 13, 2026

KPTI — Karyopharm Therapeutics Inc. Dilution Risk Tracker

Track KPTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KPTI — Get alerts when the score changes →

As of October 13, 2026, Karyopharm Therapeutics Inc. (KPTI) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. Karyopharm Therapeutics Inc. has a market capitalization of $11.45M, 22.68M shares outstanding, 84 institutional holders tracked. Stored dilution-related fields include 18.05M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
55
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 51%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 80% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 66% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration model 15%
• Score already CRITICAL (81/100) — events likely imminent
🔔 Track KPTI — Get forecast alerts →

Market Data

Market Cap$11.45M
Shares Outstanding22.68M
Float14.70M
Cash$148.40M
Debt$169.29M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore81/100DilutionWatch score record
Shares Outstanding22.68MVerified float table or market cache
Public Float14.70MVerified float table or market cache
Market Cap$11.45MMarket data cache
Cash Runway14.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants18.05MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 151.6% shares (2026Q1 vs prior)
84 institutional holders · 27.62M shares
#1 Ikarian Capital, LLC 2.57M shares
#2 Commodore Capital LP 1.95M shares
#3 RA CAPITAL MANAGEMENT, L.P. 1.92M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.06M
Days to Cover4.8
% of Float41.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-02-13
8-K 8K EVENT 2026-03-24
4 INSIDER TRANSACTION 2026-03-03
4 INSIDER TRANSACTION 2026-03-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KPTI Dilution Snapshot

Karyopharm Therapeutics Inc. (KPTI) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KPTI's DilutionScore is currently 81/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 74/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202681/100CRITICAL16 days
Aug 22 – Sep 27, 202674/100HIGH37 days
Aug 14 – Aug 21, 202668/100HIGH7 days
Jul 16 – Aug 13, 202674/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KPTI shares outstanding have increased 23.5% from 18.34M (Mar 2026) to 22.66M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 31, 202622.66M14.70M▼ 3.42%
May 22, 202622.66M15.22M▼ 15.94%
May 16, 202622.66M18.10M▲ 20.01%
Apr 07, 202622.54M15.08M▼ 17.26%
Apr 01, 202622.54M18.23M▲ 5.56%
Mar 27, 202619.62M17.27M▲ 6.18%
Mar 14, 202618.34M16.27M▼ 0.24%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KPTI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KPTI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KPTI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KPTI
KPTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.